Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
2(18%)
Results Posted
71%(5 trials)

Phase Distribution

Ph phase_3
3
27%
Ph phase_2
2
18%
Ph phase_4
1
9%
Ph not_applicable
5
45%

Phase Distribution

0

Early Stage

2

Mid Stage

4

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
3(27.3%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
5(45.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(4)
Completed(7)

Detailed Status

Completed7
Recruiting2
Not yet recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (18.2%)
Phase 33 (27.3%)
Phase 41 (9.1%)
N/A5 (45.5%)

Trials by Status

recruiting218%
not_yet_recruiting19%
completed764%
enrolling_by_invitation19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
11